The Liquid Biopsy Center (LBC) is a biobank initiative sponsored by the VUmc CCA Foundation and the Cancer Center Amsterdam.

Our goal is to uniformly collect and store various types of biofluids, such as blood and urine, from cancer patients and to create a large uniform, high quality, multicenter sample- and dataset. These uniformly collected and stored biofluids represent a unique resource for cutting edge translational cancer research to fulfill the promise of personalized cancer care.

Currently, cancer is diagnosed through painful and invasive tissue biopsies of a suspected mass. Additional (repeat) tissue biopsies are often necessary in the follow up, increasing the chance of complications. By establishing a vast collection of high quality biofluids, the LBC aims to accellerate the development of novel non-invasive liquid biopsy techniques for the detection and monitoring of cancer. These tests can be utilized for earlier cancer diagnosis, more accurate cancer prognosis and better treatment selection.

The overall aim of the Cancer Center Amsterdam Liquid Biopsy Center is illustrated in the movie above.